Benzinga - U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
- Credit Suisse Group AG (NYSE: CS) dipped 22.3% to $1.95 in pre-market trading. Saudi Arabia's SNB said it cannot give more money to Credit Suisse because cannot go above 10% ownership due to regulatory issue.
- Luna Innovations Incorporated (NASDAQ: LUNA) fell 14.3% to $8.20 in pre-market trading after the company posted weaker-than-expected Q4 results and issued weak Q1 revenue forecast.
- Vacasa, Inc. (NASDAQ: VCSA) dropped 13.7% to $1.13 in pre-market trading after reporting Q4 results.
- Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) declined 10.3% to $10.50 in pre-market trading. Merrimack Pharmaceuticals recently posted a FY22 loss of $0.11 per share.
- Freshpet, Inc. (NASDAQ: FRPT) dropped 10.2% to $49.99 in pre-market trading after the company reported a proposed convertible senior notes offering.
Don’t forget to check out our premarket coverage here
- Tremor International Ltd (NASDAQ: TRMR) fell 8.7% to $5.70 in pre-market trading after climbing around 10% on Tuesday.
- B. Riley Financial, Inc. (NASDAQ: RILY) dropped 8.6% to $29.01 in pre-market trading. Synchronoss Technologies confirmed that on March 10, 2023, it received a non-binding proposal from B. Riley Financial to acquire all outstanding shares for $1.15 per share, payable in cash.
- Deutsche Bank Aktiengesellschaft (NYSE: DB) fell 7.6% to $10.40 in pre-market trading.
- ING Groep N.V. (NYSE: ING) fell 7.5% to $11.74 in pre-market trading.
- Borr Drilling Limited (NYSE: BORR) dropped 7.3% to $6.45 in pre-market trading.
- UBS Group AG (NYSE: UBS) fell 7.3% to $18.53 in pre-market trading.
- Guess?, Inc. (NYSE: GES) dropped 6.2% to $19.96 in pre-market trading. The company posted upbeat quarterly results, but issued weak earnings forecast.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: $32M Bet On This Utilities Stock? Check Out These 3 Stocks Insiders Are Buying
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.